Clinical Trials Logo

Clinical Trial Summary

This is a platelet transfusion study. The purpose of this study is to measure the life span and quality of platelets stored in a refrigerator. Participants will give platelets by apheresis. Platelets will be stored for 3 -20 days. A small portion of the subject's own stored platelets will be tagged with a radioactive isotope and infused back into the participant. This will enable us to track how many transfused platelets survive after storage in the refrigerator.


Clinical Trial Description

A single hyperconcentrated apheresis platelet unit will be collected from a healthy adult volunteer subject using the Trima Accel® Automated Blood Collection System. Concurrent plasma will be collected. The platelet unit will be stored, not-agitated, for up to 20 days at 4°C in a suspension of 35% plasma and 65% PAS (Platelet Additive Solution).

At the end of the storage period, the subject will return to receive an 111Indium Oxine (Indium 111, In-111) radiolabeled aliquot of their 4°C stored platelets. Follow-up samples from the subject will be collected approximately 2 hours post-infusion and on Days 1 (2X), 2 (2X), and 3 to calculate recovery and survival of the subject's 4°C stored platelets. The Day 1 and Day 2 the sample draws will be 2 - 10 hours apart.

In addition to radiolabeled platelet recovery and survival measurements, various in vitro assays will be performed on the day of collection at the end of 4°C storage.

One week after the infusion of the radiolabeled aliquot, the subject will return to receive a second radiolabeled aliquot of fresh platelets. To facilitate this, on the morning of the second infusion, the subject will return for collection of a 43 mL blood sample. The blood will be processed to obtain a fresh sample of the subject's platelets to serve as a control comparator. The platelets will be radiolabeled with In-111. The subject will return later in the day for infusion of the radiolabeled fresh 'control' comparator aliquot. Follow-up blood samples will be drawn at ~2 hours after the infusion on Day 0 and then on Days 1, 2, 3, 4 or 5, and 6 or 7 day post infusion to calculate recovery and survival of the subject's fresh vs. stored platelets. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02754414
Study type Interventional
Source Bloodworks (Puget Sound Blood Center)
Contact Lynda Fitzpatrick, RN
Phone 206-689-6285
Email lyndaf@BloodWorksNW.org
Status Recruiting
Phase Phase 1
Start date April 2016
Completion date January 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06043050 - PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia (PROSPECT)
Completed NCT03110887 - Monitoring Outcome in Neonatal Thrombocytopenia N/A
Recruiting NCT03325140 - Platelet Transfusions in Critically Ill Patient
Completed NCT03814486 - Retrospective Descriptive Study of Platelet Transfusion in Patients With Palliative Hematologic Malignancies at the University Hospital of Besançon
Recruiting NCT03505086 - Bleeding In Thrombocytopenia Explained
Completed NCT03045068 - Platelet Transfusion During Neonatal Open Heart Surgery Phase 4
Completed NCT03806712 - Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)